Subcutaneous delivery of daratumumab in relapsed or refractory multiple myeloma

This study was registered at www.clinicaltrials.gov as #NCT02519452.

Source: Blood - August 21, 2019 Category: Hematology Authors: Usmani, S. Z., Nahi, H., Mateos, M.-V., van de Donk, N. W. C. J., Chari, A., Kaufman, J. L., Moreau, P., Oriol, A., Plesner, T., Benboubker, L., Hellemans, P., Masterson, T., Clemens, P. L., Luo, M., Liu, K., San-Miguel, J. Tags: Multiple Myeloma, Lymphoid Neoplasia, Clinical Trials and Observations Source Type: research